An Explosion of Agents for Myeloma Treatment
Prerna Mewawalla, MD, discusses how the treatment landscape for multiple myeloma is growing.
Key Factors for Therapy Choice in Relapsed/Refractory Multiple Myeloma
Prerna Mewawalla, MD, discusses how she approaches the choice of therapy for relapsed/refractory multiple myeloma now that many different options are available for patients.
Recent Trials Change Practice for Newly Diagnosed Multiple Myeloma
Prerna Mewawalla, MD, a hematologist at Allegheny Health Network, discusses how her approaches to patients with newly diagnosed multiple myeloma have changed recently based on clinical trial outcomes.